Screener / SEC EDGAR /CIK 0001111928 /10-K filed Feb 23, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Semiconductors

IPG Photonics Corp IPGP

Compare with peers Embed
Planned sales, announced before they happen

8 trading plans running, 17 Form 144 notices for $55.1M

10-Q, 10-K and Form 144
Plans running now 8 Mary Buttarazzi, Mr. Timothy P.V. Mammen, Mr. Eric Meurice, Dr. Eugene Scherbakov, Mr. Angelo P. Lopresti, Ms. Agnes Tang, Mr. Trevor Ness, Paulus Bucher
Plans adopted 16 reported since May 2, 2023 Form 144 notices 17 $55.1M the sellers expected to sell

What IPGP's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Mar 7, 2025 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Mary Buttarazzi
Vice President, Corporate Controller and Chief Accounting Officer
Adopted 10b5-1 plan Sep 14, 2026 10-Q Nov 3, 2026
What the company wrote
on September 14, 2026, Ms. Mary Buttarazzi, Vice President, Corporate Controller and Chief Accounting Officer of the Registrant, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 2,257 shares, including shares acquired upon vesting of restricted stock units. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until December 31, 2027, or earlier if all transactions under the trading arrangement are completed.
Mr. Timothy P.V. Mammen
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan May 28, 2026 10-Q Aug 4, 2026
What the company wrote
on May 28, 2026, Mr. Timothy P.V. Mammen, Senior Vice President and Chief Financial Officer of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 20,218 shares over a period beginning September 1, 2026 and ending May 10, 2027 on the open market at prevailing prices, subject to minimum price thresholds.
Mr. Eric Meurice
Director
Adopted 10b5-1 plan May 7, 2026 10-Q Aug 4, 2026
What the company wrote
on May 7, 2026, Mr. Eric Meurice, Director of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 5,321 shares, including shares acquired upon exercise of stock options, over a period beginning August 10, 2026 and ending August 9, 2027 on the open market at prevailing prices, subject to minimum price thresholds
Dr. Eugene Scherbakov
Director
Adopted 10b5-1 plan Mar 17, 2026 10-Q May 5, 2026
What the company wrote
on March 17, 2026 Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts: the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III (of which Dr. Scherbakov and Mr. Lopresti are trustees), and Share 1 GST Exempt Marital Share A under Article III of Valentin Gapontsev Trust I U/A DTD 08/01/2022, and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 15,240 shares by Dr. Scherbakov and up to 17,184 shares by Mr. Lopresti, over a period beginning June 17, 2026 and ending April 17, 2027 on the open market at prevailing prices, subject to minimum price thresholds.
Mr. Angelo P. Lopresti
Senior Vice President, General Counsel and Corporate Secretary
Adopted 10b5-1 plan Mar 17, 2026 10-Q May 5, 2026
What the company wrote
on March 17, 2026 Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts: the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III (of which Dr. Scherbakov and Mr. Lopresti are trustees), and Share 1 GST Exempt Marital Share A under Article III of Valentin Gapontsev Trust I U/A DTD 08/01/2022, and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 15,240 shares by Dr. Scherbakov and up to 17,184 shares by Mr. Lopresti, over a period beginning June 17, 2026 and ending April 17, 2027 on the open market at prevailing prices, subject to minimum price thresholds.
Ms. Agnes Tang
Director
Adopted 10b5-1 plan Aug 26, 2025 10-Q Nov 4, 2025
What the company wrote
During the Registrant's last fiscal quarter ended September 30, 2025, the following director of the Registrant adopted a Rule 10b5-1 trading arrangement: • on August 26, 2025, Ms. Agnes Tang, Director of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 3,392 shares over a period beginning November 24, 2025 and ending November 24, 2026 on the open market at prevailing prices, subject to minimum price thresholds.
Dr. Eugene Scherbakov
Director
Adopted 10b5-1 plan Jun 13, 2025 10-Q Aug 5, 2025
What the company wrote
on June 13, 2025, Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts (of which Dr. Scherbakov and Mr. Lopresti are trustees): the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 16,000 shares by Dr. Scherbakov and up to 6,000 shares by Mr. Lopresti, over a period beginning September 15, 2025 and ending February 27, 2026 on the open market at prevailing prices, subject to minimum price thresholds.
Mr. Angelo P. Lopresti
Senior Vice President
Adopted 10b5-1 plan Jun 13, 2025 10-Q Aug 5, 2025
What the company wrote
on June 13, 2025, Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts (of which Dr. Scherbakov and Mr. Lopresti are trustees): the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 16,000 shares by Dr. Scherbakov and up to 6,000 shares by Mr. Lopresti, over a period beginning September 15, 2025 and ending February 27, 2026 on the open market at prevailing prices, subject to minimum price thresholds.
Mr. Trevor Ness
Senior Vice President
Adopted 10b5-1 plan May 28, 2025 10-Q Aug 5, 2025
What the company wrote
on May 28, 2025, Mr. Trevor Ness, Senior Vice President, Sales and Strategic Business Development of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 6,715 shares over a period beginning August 18, 2025 and ending February 17, 2026 on the open market at prevailing prices, subject to minimum price thresholds
Angelo Lopresti
Senior Vice President, General Counsel and Corporate Secretary of the Registrant
Ended 10b5-1 plan Mar 17, 2025 10-Q May 6, 2025
What the company wrote
on March 17, 2025, Mr. Angelo Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, terminated the Rule 10b5-1 trading arrangement for the sale of up to 10,000 shares over a period beginning March 17, 2025 and ending December 1, 2025 on the open market at prevailing prices, subject to minimum price thresholds.
Eric Meurice
Director
Adopted 10b5-1 plan Mar 7, 2025 10-Q May 6, 2025
What the company wrote
on March 7, 2025, Mr. Eric Meurice, Director, adopted a Rule 10b5-1 trading arrangement for the sale of up to 3,002 shares, including shares acquired upon exercise of stock options, over a period beginning June 7, 2025 and ending June 1, 2026 on the open market at prevailing prices, subject to minimum price thresholds; and
Mr. Angelo Lopresti
Senior Vice President, General Counsel and Corporate Secretary
Ended 10b5-1 plan Dec 13, 2024 10-K Feb 20, 2025
Eric Meurice
Director
Adopted 10b5-1 plan May 3, 2024 10-Q Jul 30, 2024
What the company wrote
on May 3, 2024, Mr. Eric Meurice, Director, adopted a Rule 10b5-1 trading arrangement for the sale of up to 2,255 shares, including shares acquired upon exercise of stock options, over a period beginning August 2, 2024 and ending June 1, 2025 on the open market at prevailing prices, subject to minimum price thresholds.
Angelo P. Lopresti
Senior Vice President, General Counsel and Corporate Secretary
Adopted 10b5-1 plan Mar 12, 2024 10-Q Apr 30, 2024
What the company wrote
on March 12, 2024, Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary, adopted a Rule 10b5-1 trading arrangement for the sale of up to 10,000 shares, over a period beginning June 13, 2024 and ending June 12, 2025 on the open market at prevailing prices, subject to minimum price thresholds.
Ms. Agnes Tang
Director
Adopted 10b5-1 plan Jun 15, 2023 10-Q Aug 1, 2023
What the company wrote
on June 15, 2023, Ms. Agnes Tang, Director, adopted a Rule 10b5-1 trading arrangement for the sale of up to 900 shares over a period beginning September 13, 2023 and ending March 31, 2024 on the open market at prevailing prices, subject to minimum price thresholds.
Dr. Eugene Scherbakov
Director and CEO
Adopted 10b5-1 plan May 10, 2023 10-Q Aug 1, 2023
What the company wrote
on May 10, 2023, Dr. Eugene Scherbakov, Director and CEO, adopted a Rule 10b5-1 trading arrangement for the sale of up to 13,000 shares, including shares acquired upon exercise of stock options, over a period beginning August 13, 2023 and ending February 28, 2024 on the open market at prevailing prices, subject to minimum price thresholds
Mr. Trevor Ness
Senior Vice President, Chief Revenue Officer
Adopted 10b5-1 plan – 10-Q May 5, 2026
What the company wrote
on March 17, 2026, Mr. Trevor Ness, Senior Vice President, Chief Revenue Officer of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 12,212 shares, including shares acquired upon exercise of stock options, over a period beginning June 17, 2026 and ending June 16, 2027 on the open market at prevailing prices, subject to minimum price thresholds
Paulus Bucher
Senior Vice President, Global Operations
Adopted 10b5-1 plan – 10-Q Nov 3, 2026
What the company wrote
on August 27, 2026, Mr. Paulus Bucher, Senior Vice President, Global Operations of the Registrant, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 2,604 shares, including shares acquired upon vesting of restricted stock units. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until May 10, 2027, or earlier if all transactions under the trading arrangement are completed.
Show the other 10 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 17 filings checked since May 2, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 2, 2026 IP FIBRE DEVICES LTD
10% Stockholder
135,000 $11.6M
Oct 2, 2026 SCHERBAKOV EUGENE A
10% Stockholder
7,620 $650K
Sep 22, 2026 Valentin Gapontsev Trust II
Officer
11,688 $909K
Jun 29, 2026 Lopresti Angelo P
Officer
3,000 $331K
Jun 29, 2026 IP FIBRE DEVICES LTD
10% Stockholder
197,100 $20.4M
Jun 29, 2026 SCHERBAKOV EUGENE A
Director
4,572 $464K
Jun 22, 2026 Valentin Gapontsev Trust II
Officer
12,876 $1.5M
Jun 22, 2026 Agnes Tang
Director
1,511 $178K
May 22, 2026 Mammen Timothy PV
Officer
9,975 $1.2M
May 14, 2026 Desmond Jeanmarie F.
Director
1,690 $178K
Mar 17, 2026 Buttarazzi Mary E.
Officer
500 $58K
Feb 2, 2026 Meurice Eric
Director
750 $71K
Jan 21, 2026 Lopresti Angelo P
Officer
1,500 $128K
Dec 23, 2025 SCHERBAKOV EUGENE A
Officer
8,100 $603K
Dec 22, 2025 IP FIBRE DEVICES LTD
10% Stockholder
192,501 $14.6M
Dec 19, 2025 Valentin Gapontsev Trust II
Officer
27,945 $2.1M
Nov 25, 2025 Agnes Tang
Director
1,881 $144K
Show the other 9 notices

From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IPGP/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.